MoonLake Immunotherapeutics
MLTX
$16.47
-$0.03-0.18%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 537.03M | 357.92M | 393.97M | 380.48M | 425.08M |
| Total Receivables | 6.56M | 5.76M | 4.87M | 4.02M | 3.41M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 26.45M | 32.96M | 22.86M | 26.71M | 26.99M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 570.04M | 396.64M | 421.69M | 411.22M | 455.48M |
|
|
|||||
| Total Current Assets | 570.04M | 396.64M | 421.69M | 411.22M | 455.48M |
| Net Property, Plant & Equipment | 2.57M | 2.39M | 2.14M | 2.53M | 2.92M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.34M | 1.34M | 596.00K | 587.00K | 1.70M |
| Total Assets | 573.95M | 400.37M | 424.43M | 414.34M | 460.10M |
|
|
|||||
| Total Accounts Payable | 17.04M | 23.38M | 365.00K | 653.00K | 602.00K |
| Total Accrued Expenses | 24.76M | 20.42M | 42.79M | 45.20M | 24.37M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.25M | 920.00K | 1.23M | 1.50M | 1.55M |
| Total Finance Division Other Current Liabilities | 2.35M | 1.40M | 1.09M | 1.01M | 836.00K |
| Total Other Current Liabilities | 2.35M | 1.40M | 1.09M | 1.01M | 836.00K |
| Total Current Liabilities | 45.39M | 46.11M | 45.48M | 48.37M | 27.36M |
|
|
|||||
| Total Current Liabilities | 45.39M | 46.11M | 45.48M | 48.37M | 27.36M |
| Long-Term Debt | 99.51M | 99.02M | 74.10M | 73.74M | 73.38M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 772.00K | 865.00K | 374.00K | 486.00K | 836.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 74.00K | 353.00K | -- | 549.00K | 574.00K |
| Total Liabilities | 145.75M | 146.35M | 119.95M | 123.14M | 102.15M |
|
|
|||||
| Common Stock & APIC | 1.02B | 786.32M | 766.79M | 689.11M | 683.97M |
| Retained Earnings | -594.42M | -532.62M | -462.91M | -400.49M | -330.76M |
| Treasury Stock & Other | 630.00K | 322.00K | 604.00K | 278.00K | 520.00K |
| Total Common Equity | 428.20M | 254.02M | 304.48M | 288.91M | 353.73M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 428.20M | 254.02M | 304.48M | 288.91M | 353.73M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | 2.29M | 4.21M |
| Total Equity | 428.20M | 254.02M | 304.48M | 291.19M | 357.94M |
|
|
|||||